Skip to content
★ Sign in to follow
RM
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 02 Feb 2026 for Altimmune, Inc., €12k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Raymond M. Jordt: trading record in brief

This profile gathers the share dealings of Raymond M. Jordt in Altimmune, Inc. We count 18 filings; the first trade dates from 31 July 2023 and the latest from 31 January 2026.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 2 February 2026 came the latest disclosure, a share grant for €12k in Altimmune, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Raymond M. Jordt

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    14,033 USD12SEC
    4,571 shares@ US$3.0712.5% of flowCommon Stock, par value $0.0001SEC:0001960780-26-000008:0
  • ◇
    Chief Business OfficerExecutivesAltimmune, Inc.
    0SEC
    15,850 shares0Common Stock, par value $0.0001SEC:0001960780-26-000006:0
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    21,203 USD13SEC
    3,855 shares@ US$5.5019.2% of flowCommon Stock, par value $0.0001SEC:0001960780-26-000004:1
  • ◇
    Chief Business OfficerExecutivesAltimmune, Inc.
    0SEC
    14,600 shares0Common Stock, par value $0.0001SEC:0001960780-26-000004:0
  • ◇
    Chief Business OfficerExecutivesAltimmune, Inc.
    0SEC
    9,375 shares0Common Stock, par value $0.0001SEC:0001960780-26-000002:0
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    4,296 USD11SEC
    1,368 shares@ US$3.144.0% of flowCommon Stock, par value $0.0001SEC:0001104659-25-073629:0
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    13,541 USD12SEC
    2,614 shares@ US$5.1813.8% of flowCommon Stock, par value $0.0001SEC:0001104659-25-008771:0
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    26,957 USD14SEC
    3,862 shares@ US$6.9827.5% of flowCommon Stock, par value $0.0001SEC:0001104659-25-006843:1
  • ◇
    Chief Business OfficerExecutivesAltimmune, Inc.
    0SEC
    14,600 shares0Common Stock, par value $0.0001SEC:0001104659-25-006843:0
  • ◇
    Chief Business OfficerExecutivesAltimmune, Inc.
    0SEC
    9,375 shares0Common Stock, par value $0.0001SEC:0001104659-25-000836:0
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    4,961 USD11SEC
    917 shares@ US$5.414.9% of flowCommon Stock, par value $0.0001SEC:0001104659-24-084993:0
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    13,531 USD12SEC
    5,030 shares@ US$2.6913.3% of flowCommon Stock, par value $0.0001SEC:0001104659-24-009542:0
  • ◇
    Chief Business OfficerExecutivesAltimmune, Inc.
    0SEC
    9,375 shares0Common Stock, par value $0.0001SEC:0001104659-24-001463:0
  • ◆
    Chief Business OfficerExecutivesAltimmune, Inc.
    5,148 USD11SEC
    1,832 shares@ US$2.815.0% of flowCommon Stock, par value $0.0001SEC:0001104659-23-086899:0

14 of 14 declarations